ClinicalTrials.gg
CompletedNCT03508973Updated Apr 26, 2018

Sculptra for Décolletage Crepiness and Wrinkling

An interventional study of Sculpta in Décolletage, sponsored by Skin Laser & Surgery Specialists. Completed. Open to female participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-26.

Sponsored by Skin Laser & Surgery Specialists · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2015, registered May 2016).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
40 Years to 70 Years
Sex
Female
01

Study summary

The purpose of this study is to evaluate the safety and efficacy of Sculptra as a volume agent to improve décolletage crepiness and wrinkling.

02

Conditions studied

  • Décolletage
03

In context

Lead sponsor

Skin Laser & Surgery Specialists is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female volunteer
  • Aged from 40-70 years on the day of screening
  • No known medical conditions that may interfere with study participation
  • Moderate to severe crepiness and wrinkling of the décolletage
  • Willingness to not use any products on their décolleté for the duration of the study
  • Read, understand, and sign forms
  • Willingness to sign photography release form
  • Willing and able to comply with all follow-up requirements
  • Willingness to undergo a series of three Sculptra injections, 2-3 months apart, in their décolletage

Exclusion criteria

Exclusion Criteria:

  • Any significant skin disease at treatment area
  • Any medical condition which could interfere with the treatment
  • Inability or unwillingness to follow the treatment schedule
  • Inability or unwillingness to sign the
  • History of poor wound healing
  • History of keloid formation
  • History of , hepatitis, immuno-compromised
  • Pregnant or lactating
  • Previous use of deep chemical peels on the treatment area
  • Previous injections of Sculptra in the décolletage
  • Known to Sculptra or any of its ingredients
  • Previous laser or light based treatments to the treatment area 6 months prior to the screening visit
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Sculptra

    Sculptra, an injectable implant containing microparticles of ply-L-lactic acid, carboxymethylcellulose, non-pyrogenic mannitol and sterile water, will be injected into the decolletage.

    Other: Sculpta

Interventions

  • OtherSculpta
06

What researchers measure

Primary outcomes

  1. Change in décolletage crepiness and wrinkling in treatment area as measured by 5 point décolletage wrinkle scale

    Time frame: Screening, Treatment 1, Treatment 2, Treatment 3, 1 Month Follow up, 3 Month Follow up and 6 Month Follow up

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2015 to primary completion in Dec 2016, 13 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 26, 2016
First posted
Apr 26, 2018
StartActual
Nov 9, 2015
Primary completionActual
Dec 13, 2016
CompletionActual
Dec 13, 2016
Last update
Apr 26, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03508973
Lead sponsor
Skin Laser & Surgery Specialists
Responsible party
David J. Goldberg, MD (David J. Goldberg, MD, JD, Skin Laser & Surgery Specialists) — Principal investigator
First posted
Apr 26, 2018
Start date
Nov 9, 2015
Primary completion
Dec 13, 2016
Completion
Dec 13, 2016
Last update
Apr 26, 2018
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion